Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q1 2023 Earnings Call Transcript

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q1 2023 Earnings Call Transcript May 8, 2023

Ocular Therapeutix, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.26.

Operator: Good day, and thank you for standing by. Welcome to the Ocular Therapeutics First Quarter 2023 Earnings Conference Call. . Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Donald Notman, Chief Financial...